The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
NCT06111781
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Relugolix 120 MG [Orgovyx]
RADIATION:
SBRT standard of care radiotherapy treatment
Sponsor
Yale University
Collaborators
[object Object]